News | Published:

First deuterated drug approved

Nature Biotechnology 35, 493–494 (2017) | Download Citation

Subjects

  • A Correction to this article was published on 09 November 2017

This article has been updated

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

Rent or Buy

All prices are NET prices.

Change history

  • 13 April 2018

    In the version of this article initially published, the drug BMS-986165 was listed as a "deuterium-modified" version of rosuvastatin, rather than a "deuterium-modified" new molecular entity. The error has been corrected in the HTML and PDF versions of the article.

Author information

Affiliations

  1. Portland, Oregon

    • Charles Schmidt

Authors

  1. Search for Charles Schmidt in:

To obtain permission to re-use content from this article visit RightsLink.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt0617-493

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing